Epi-Immunotherapy in Cancer Treatment:Mechanisms,Clinical Progress,and Future DirectionsOA
Epi-Immunotherapy in Cancer Treatment:Mechanisms,Clinical Progress,and Future Directions
Nannan Lu;Guanghua Rong;Weidong Han
Department of Bio-therapeutic,the First Medical Centre,Chinese PLA General Hospital,Beijing,ChinaDepartment of Bio-therapeutic,the Fifth Medical Centre,Chinese PLA General Hospital,Beijing,ChinaDepartment of Bio-therapeutic,the Fifth Medical Centre,Chinese PLA General Hospital,Beijing,China
cancerepigeneticsepi-immunotherapyimmunotherapytumor immune evasiontumor microenvironment
cancerepigeneticsepi-immunotherapyimmunotherapytumor immune evasiontumor microenvironment
《肿瘤学创新（英文）》 2025 (5)
30-53,24
This study was supported by the National Natural Science Foundation of China(82341208,82430012).
评论